Command Palette

Search for a command to run...

NECLIFE
13.86(-1.70%)
1W: -2.08%

Nectar Lifesciences Key Ratios

Cash Conversion Cycle

Latest:81.3 days

Return on Equity

Latest:0.5%

Return on Capital Employed

Latest:6.5%

Dupont Analysis

Analysis Summary

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024
ROE2.84%-6.67%2.33%-2.25%0.47%
PAT margin0.30%-1.59%1.50%-4.75%1.37%
Asset Turnover0.99x0.70x0.81x0.77x0.89x
Leverage2.38x2.28x2.22x2.12x2.04x

Efficiency Ratios

Analysis Summary

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Inventory Days130.9162.0118.3139.2130.9
Receivable Days65.979.777.975.962.4
Payable Days99.3137.1107.3109.5112.1
Cash Conversion Cycle97.6104.688.9105.781.3

Return Ratios

Analysis Summary

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024
ROE2.84%-6.67%2.33%-2.25%0.47%
ROCE8.32%1.41%5.77%2.49%6.54%
ROA1.19%-2.93%1.05%-1.06%0.23%

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.